Monoclonal Antibodies Targeting Amyloid for Alzheimer Disease
Автор: JAMA Network
Загружено: 2023-10-10
Просмотров: 2337
In this interview, dementia expert Gil D. Rabinovici, MD, discusses monoclonal antibodies that target beta-amyloid–-including a recent phase 3 trial of donanemab published in JAMA-–and reviews considerations for their use in patients with Alzheimer disease.
Related Content:
Amyloid-Targeting Monoclonal Antibodies for Alzheimer Disease
https://ja.ma/45fl0b5
Donanemab in Early Symptomatic Alzheimer Disease
https://ja.ma/3DN6YBQ
Podcast was originally published on August 3, 2023.
https://edhub.ama-assn.org/jn-learnin...
---------------------------------------------------------------------------------
Follow JAMA Clinical Reviews on:
Youtube: • JAMA Clinical Reviews
Apple Podcasts: https://podcasts.apple.com/us/podcast...
Spotify: https://open.spotify.com/show/229VuDi...
Pocket Casts: https://pca.st/3ghw
Your podcast app of choice: https://pod.link/1027430378
Website: https://jamanetwork.com/journals/jama...
---------------------------------------------------------------------------------
For more from JAMA
• https://www.jama.com
• / jamajournal
• / jama_current
• / jamanetwork
Follow the JAMA Network
• https://www.jamanetwork.com
• http://www.jamanetworkaudio.com
• / jamanetwork
• / jamanetwork
• / jamanetwork
• / jamanetwork
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
